erythromycin has been researched along with sulfapyridine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Esterly, NB; Flanagan, LE; Furey, NL | 1 |
Buschmann, G; Duprée, C | 1 |
Jiang, B; Jing, XL; Li, GA; Li, SS; Ling, WC; Sui, SS; Sun, CY; Wang, YL | 1 |
5 other study(ies) available for erythromycin and sulfapyridine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The effect of antimicrobial agents on leukocyte chemotaxis.
Topics: Anti-Infective Agents; Chemotaxis, Leukocyte; Clindamycin; Dapsone; Erythromycin; Humans; Leukocytes; Penicillin G; Sulfapyridine; Tetracycline | 1978 |
[Oral treatment of udder actinomycosis in swine].
Topics: Actinomycosis; Administration, Oral; Animals; Drug Combinations; Erythromycin; Female; Mammary Glands, Animal; Nitrofurazone; Sulfaguanidine; Sulfanilamides; Sulfapyridine; Swine; Swine Diseases | 1976 |
[Pollution Characteristics and Risk Assessment of Antibiotics in Beiyun River Basin in Beijing].
Topics: Anti-Bacterial Agents; Azithromycin; Beijing; Clarithromycin; Erythromycin; Lincomycin; Ofloxacin; Risk Assessment; Rivers; Roxithromycin; Sulfapyridine; Tandem Mass Spectrometry | 2023 |